Hier finden Sie grundlegende Angaben zu klinischen Studien des Comprehensice Cancer Centers Mainfranken (CCC MF)
Filter aktiv
Seite 31 - Studien 301 bis 310 von insgesamt 340
- Rekrutierung läuftMale breast cancer - A prospective registry study of the University Women's Hospital Magdeburg in cooperation with the GBG (German Breast Group) on the diagnosis and treatment of male breast cancerDRKS00009536Indikationen
- Rekrutierung läuftTumor-Treating-Fields (Optune™) in der Routineanwendung bei der Primärtherapie des Glioblastoms: multizentrische Registerstudie zur Erfassung der Therapieeffektivität und des Rezidivmusters“
- Rekrutierung läuftPROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive or HER2-low Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan (PROVIDENCE)Indikationen
- Rekrutierung läuftRetentionsrate von Acalabrutinib in einem nicht-interventionellen Setting
- Rekrutierung läuftClinical Research Platform For Molecular Testing, Treatment, Quality Of Life And Outcome Of Patients With Esophageal, Gastric Or Gastroesophageal Junction Cancer Requiring Palliative Systemic Therapy (SAPHIR)
- Rekrutierung läuft
Prospective Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcome Data in Ovarian Cancer Patients Eligible for First-line Platinum-based Chemotherapy and Intended for BRCA/HRD Testing
Molekulare Marker - Rekrutierung läuftA non-interventional study of selinexor (Nexpovio) in combination with bortezomib and dexamethasone (SVd) in patients with relapsed or refractory multiple myeloma (R/RMM) - SEATTLE -
- Rekrutierung läuftA non-interventional study of selinexor (Nexpovio) in combination with bortezomib and dexamethasone (SVd) in patients with relapsed or refractory multiple myeloma (R/RMM) - SEATTLE -
- Rekrutierung läuftA non-interventional study of selinexor (Nexpovio) in combination with bortezomib and dexamethasone (SVd) in patients with relapsed or refractory multiple myeloma (R/RMM) - SEATTLE -
- Rekrutierung läuftAn International Clinical Program for the diagnosis and Treatment of children, adolescents and young adults with ependymoma